In fact, the antidiabetic drug metformin has been investigated as an anti-cancer agent due to its ability to promote the activity of AMPK, suppress the action of mTOR, and subsequently attenuate SHH/GLI signaling. The gene discussed is MTOR; the disease is cancer.